Autologous hematopoietic transplantation following COVID‐19 infection
Autologous hematopoietic transplantation following COVID‐19 infection
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (N Engl J Med 2017, 376; 1311). Though active COVID‐19 infection is typically a contraindication to aggressive therapy, little is known about the safety of autologous transplantation after resolution...
Alternative Titles
Full title
Autologous hematopoietic transplantation following COVID‐19 infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_32999b8e299d46138c60f6c233de5bdd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32999b8e299d46138c60f6c233de5bdd
Other Identifiers
ISSN
2050-0904
E-ISSN
2050-0904
DOI
10.1002/ccr3.3712
